Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

(MedPage Today) -- VIENNA -- Tenofovir alafenamide (TAF; Biktarvy) continued to be highly effective for chronic hepatitis B virus (HBV) infection for up to 8 years, according to an analysis of long-term data. Over this time period, viral suppression...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news